| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,726 | 24,176 | 23,786 | 30,065 | | Cost of Revenue | 10,995 | 11,538 | 11,794 | 12,835 | | | Gross Profit | 11,731 | 12,638 | 11,992 | 17,230 | | | Operating Expenses | | Research Development | 989 | 993 | 1,149 | 1,171 | | Selling General and Administrative | 6,033 | 6,801 | 7,503 | 7,467 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,709 | 4,844 | 3,340 | 8,592 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (82) | (409) | 116 | 808 | | Earnings Before Interest And Taxes | 4,627 | 4,435 | 3,456 | 9,400 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 4,627 | 4,435 | 3,456 | 9,400 | | Income Tax Expense | 1,808 | 1,887 | 1,386 | 3,734 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,819 | 2,548 | 2,070 | 5,666 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,819 | 2,548 | 2,070 | 5,666 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,819 | $2,548 | $2,070 | $5,666 |
|
0.51% Nasdaq 
Income Statement
